Arvinas (ARVN) provided an update on its collaboration with Pfizer (PFE) for the co-development of vepdegestrant, an investigational oral Protac estrogen receptor protein degrader, and announced ...

Arvinas and Pfizer have been working to develop vepdegestrant, an estrogen receptor protein degrader under review by the Food and Drug Administration as a breast cancer treatment. The companies said ...

Medically reviewed by Renita White, MD Perimenopause is the transition period leading up to menopause (the end of your menstrual period). During this time, your estrogen levels begin to drop, your ...

Women are constantly overwhelmed with diet, health and lifestyle advice, yet are rarely the sole focus of exercise science ...

British scientists experimenting with mice believe they may have found why post-menopausal women often suffer from osteoporosis. The researchers discovered that mice lacking a key estrogen-regulating ...

Risks for developing Alzheimer’s disease can increase or decrease depending on when women begin hormone replacement therapy, ...

A growing understanding of how “reproductive” hormones sculpt the brain could transform the management of neurological conditions. Credit...Yuko Shimizu Supported by By Rachel E. Gross Estrogen is the ...

Specimen pairs from 39 patients were tissue arrayed and stained for ER, progesterone receptor (PgR), Bcl-2, c-ErbB2 (HER-2), and phosphorylated (p) p38 mitogen-activated protein kinase (MAPK), ...

However, increasing protein intake has been shown to reduce muscle loss while healing from injury, according to research in ...

Higher activity of PGC-1α enables brown fat cells in females to thermogenic activity and energy expenditure compared to males ...